πŸ‡ΊπŸ‡Έ FDA
Patent

US 11654193

Cancer treatment combinations

granted A61KA61K2039/505A61K2039/804

Quick answer

US patent 11654193 (Cancer treatment combinations) held by The Regents of the University of California expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/804, A61K31/519, A61K39/39558